- Published at
- by seekingalpha.com
mixed
mixed
Biopharma Firm FibroBiologics Seeks U.S. Direct Listing (Pending:FBLG)
FibroBiologics' lead candidate, CYMS101, has received FDA clearance for a Phase 1/2 clinical trial for DDD. Read more to see our analysis on FBLG.